4.7 Review

New insights into the role and mechanisms of ginsenoside Rg1 in the management of Alzheimer's disease

Journal

BIOMEDICINE & PHARMACOTHERAPY
Volume 152, Issue -, Pages -

Publisher

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.biopha.2022.113207

Keywords

Alzheimer's disease; Ginsenoside Rg1; Pharmacological effects

Funding

  1. National Natural Science Foundation of China [81503272, 81630101]
  2. Application Foundation Research Project of Sichuan Provincial Department of Science and Technology [2017JY0187]
  3. Xinglin Scholar Research Premotion Project of Chengdu University of TCM [2018016]

Ask authors/readers for more resources

Alzheimer's disease is a common neurodegenerative disorder in the elderly, characterized by memory loss and cognitive dysfunction. Ginsenoside Rg1, the main component of ginseng roots, has shown therapeutic effects in the treatment of Alzheimer's disease. This review summarizes the therapeutic effects and mechanisms of ginsenoside Rg1 and its derivatives in Alzheimer's disease.
Alzheimer's disease (AD) is a common neurodegenerative disorder in the elderly characterized by memory loss and cognitive dysfunction. The pathogenesis of AD is complex. One-targeted anti-AD drugs usually fail to delay AD progression. Traditional Chinese medicine records have documented the use of the roots of Panax ginseng (ginseng roots) and its prescriptions to treat dementia. Ginsenoside Rg1, the main ginsenoside component of ginseng roots, exhibits a certain therapeutic effect in the abovementioned diseases, suggesting its potential in the management of AD. Therefore, we combed the pathogenesis of AD and currently used anti-AD drugs, and reviewed the availability, pharmacokinetics, and pharmaceutic studies of ginsenoside Rg1. This review summarizes the therapeutic effects and mechanisms of ginsenoside Rg1 and its deglycosylated derivatives in AD in vivo and in vitro. The main mechanisms include improvement in Ap and Tau pathologies, regulation of synaptic function and intestinal microflora, and reduction of inflammation, oxidative stress, and apoptosis. The underlying mechanisms mainly involve the regulation of PKC, MAPK, PI3K/Akt, CDK5, GSK-3 beta, BDNF/TrkB, PKA/CREB, FGF2/Akt, p21WAF1/CIP1, NF-0, NLRP1, TLR3, and TLR4 signaling pathways. As the effects and underlying mechanisms of ginsenoside Rg1 on AD have not been systematically reviewed, we have provided a comprehensive review and shed light on the future directions in the utilization of ginsenoside Rg1 and ginseng roots as well as the development of anti-AD drugs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available